title: Mass spectrometry-guided optimization and characterization of a biologically active transferrin-lysozyme model drug conjugate.
abstract: Transferrin is a promising drug carrier that has the potential to deliver metals, small organic molecules and therapeutic proteins to cancer cells and/or across physiological barriers (such as the blood-brain barrier). Despite this promise, very few transferrin-based therapeutics have been developed and reached clinical trials. This modest success record can be explained by the complexity and heterogeneity of protein conjugation products, which also pose great challenges to their analytical characterization. In this work, we use lysozyme conjugated to transferrin as a model therapeutic that targets the central nervous system (where its bacteriostatic properties may be exploited to control infection) and develop analytical protocols based on electrospray ionization mass spectrometry to characterize its structure and interactions with therapeutic targets and physiological partners critical for its successful delivery. Mass spectrometry has already become an indispensable tool facilitating all stages of the protein drug development process, and this work demonstrates the enormous potential of this technique in facilitating the development of a range of therapeutically effective protein-drug conjugates.
authors.affiliation: Department of Chemistry, University of Massachusetts Amherst, Amherst, Massachusetts 01003, United States.
authors.forename: Son N
authors.initials: SN
authors.lastname: Nguyen
authors.forename: Cedric E
authors.initials: CE
authors.lastname: Bobst
authors.forename: Igor A
authors.initials: IA
authors.lastname: Kaltashov
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000737:chemistry; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000737:chemistry; D002491:Central Nervous System Agents / Q000008:administration & dosage / Q000737:chemistry; D002626:Chemistry, Pharmaceutical; D004337:Drug Carriers / Q000737:chemistry*; D006801:Humans; D008837:Micrococcus / Q000187:drug effects; D015394:Molecular Structure; D009113:Muramidase / Q000008:administration & dosage / Q000737:chemistry* / Q000378:metabolism; D011485:Protein Binding; D011990:Receptors, Transferrin / Q000378:metabolism; D021241:Spectrometry, Mass, Electrospray Ionization; D014168:Transferrin / Q000008:administration & dosage / Q000737:chemistry* / Q000378:metabolism
chemical_list: D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D002491:Central Nervous System Agents; D004337:Drug Carriers; D011990:Receptors, Transferrin; D014168:Transferrin; D009113:Muramidase
references.citation: Anal Chem. 2013 Feb 5;85(3):1699-704
references.pmid: 23289544
references.citation: Curr Pharm Biotechnol. 2011 Oct;12(10):1517-29
references.pmid: 21542797
references.citation: J Pharm Sci. 1996 Dec;85(12):1306-11
references.pmid: 8961144
references.citation: Pharm Res. 2007 Sep;24(9):1759-71
references.pmid: 17619996
references.citation: Clin Immunol. 2006 Nov;121(2):144-58
references.pmid: 16904380
references.citation: Anal Chem. 2012 Mar 20;84(6):2843-9
references.pmid: 22384990
references.citation: Anal Bioanal Chem. 2006 Oct;386(3):689-98
references.pmid: 16924382
references.citation: Pharm Res. 2004 Feb;21(2):278-84
references.pmid: 15032309
references.citation: Nat Methods. 2008 Nov;5(11):927-33
references.pmid: 18974734
references.citation: N Engl J Med. 2012 Nov 8;367(19):1847-8
references.pmid: 23134386
references.citation: Rev Recent Clin Trials. 2006 May;1(2):119-31
references.pmid: 18473963
references.citation: Biotechnol Adv. 2012 Jan-Feb;30(1):210-22
references.pmid: 21619926
references.citation: Biochem Med. 1977 Aug;18(1):52-7
references.pmid: 901430
references.citation: Mol Cell Proteomics. 2010 Sep;9(9):2063-75
references.pmid: 20811074
references.citation: J Neurosurg. 1989 Feb;70(2):240-8
references.pmid: 2783608
references.citation: Proc Natl Acad Sci U S A. 2010 May 4;107(18):8123-8
references.pmid: 20404192
references.citation: ChemMedChem. 2010 Aug 2;5(8):1335-43
references.pmid: 20564276
references.citation: Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2820-4
references.pmid: 7708731
references.citation: Trends Pharmacol Sci. 2002 May;23(5):206-9
references.pmid: 12007993
references.citation: J Am Soc Mass Spectrom. 2008 Sep;19(9):1239-46
references.pmid: 18602274
references.citation: J Am Soc Mass Spectrom. 2010 Mar;21(3):323-37
references.pmid: 19963397
references.citation: Biochemistry. 2006 May 30;45(21):6663-73
references.pmid: 16716077
references.citation: Annu Rev Biochem. 2007;76:167-93
references.pmid: 17328674
references.citation: Int J Clin Pharmacol Ther. 2005 Dec;43(12):583-5
references.pmid: 16372526
references.citation: Anal Chem. 2011 Dec 15;83(24):9251-9
references.pmid: 22047453
references.citation: Proc Natl Acad Sci U S A. 2005 May 17;102(20):7292-6
references.pmid: 15870205
references.citation: Biochemistry. 1973 Aug 14;12(17):3266-73
references.pmid: 4581787
references.citation: Curr Pharm Des. 2002;8(9):671-93
references.pmid: 11945164
references.citation: Biotechnol Lett. 2007 Jul;29(7):985-94
references.pmid: 17464453
references.citation: Biochim Biophys Acta. 2012 Mar;1820(3):417-26
references.pmid: 21726602
references.citation: Anal Biochem. 1996 Apr 5;236(1):114-25
references.pmid: 8619475
references.citation: Rapid Commun Mass Spectrom. 2005;19(13):1806-14
references.pmid: 15945030
references.citation: Curr Opin Mol Ther. 2005 Oct;7(5):483-92
references.pmid: 16248284
references.citation: J Proteome Res. 2012 Apr 6;11(4):2048-60
references.pmid: 22320401
references.citation: Nat Rev Drug Discov. 2012 Jun 29;11(7):527-40
references.pmid: 22743980
references.citation: Expert Rev Anti Infect Ther. 2008 Feb;6(1):83-99
references.pmid: 18251666
references.citation: J Control Release. 2009 Feb 10;133(3):178-84
references.pmid: 18992290
references.citation: Nat Biotechnol. 2006 Dec;24(12):1551-7
references.pmid: 17160061
references.citation: Pharm Res. 2003 Aug;20(8):1231-8
references.pmid: 12948021
references.citation: J Trop Pediatr. 2003 Feb;49(1):13-6
references.pmid: 12630714
references.citation: J Mass Spectrom. 2003 May;38(5):491-501
references.pmid: 12794869
references.citation: Annu Rev Med. 2013;64:15-29
references.pmid: 23043493
references.citation: J Am Soc Mass Spectrom. 2012 Jul;23(7):1293-7
references.pmid: 22562395
references.citation: Biochemistry. 2000 Aug 22;39(33):10023-33
references.pmid: 10955990
references.citation: Inorg Chem. 2008 Jan 7;47(1):17-9
references.pmid: 18067289
references.citation: Proc Natl Acad Sci U S A. 2012 Aug 21;109(34):13544-8
references.pmid: 22869744
references.citation: Biochim Biophys Acta. 1952 Mar;8(3):302-9
references.pmid: 14934741
references.citation: Clin Cancer Res. 1996 Jun;2(6):1009-15
references.pmid: 9816262
references.citation: J Control Release. 2007 Feb 26;117(3):403-12
references.pmid: 17239470